Related Experiment Video
Updated: Jul 5, 2026
07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Epigenetic dysregulation in thyroid neoplasia
Tetsuo Kondo1, Sylvia L Asa, Shereen Ezzat
1Department of Pathology, University of Yamanashi, Japan.
Summary
Epigenetic gene silencing plays a crucial role in thyroid cancer development. Understanding these epigenetic changes offers new avenues for thyroid cancer diagnosis and targeted therapies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Thyroid carcinogenesis involves oncogene mutations and tumor suppressor gene inactivation.
- Epigenetic events are increasingly recognized for their role in human tumorigenesis.
- Epigenetic silencing of tumor suppressor and thyroid hormone-related genes occurs in thyroid tumors.
Purpose of the Study:
- To review evidence of epigenetic gene dysregulation in follicular cell-derived thyroid carcinomas.
- To discuss the role of epigenetics in the development and progression of thyroid cancer.
- To explore future applications of epigenetics in thyroid cancer diagnostics and therapeutics.
Main Methods:
- Literature review of studies on epigenetic gene dysregulation in thyroid cancer.
- Analysis of evidence for epigenetic silencing in papillary, follicular, and undifferentiated thyroid carcinomas.
- Synthesis of current understanding of epigenetic mechanisms in thyroid tumorigenesis.
Main Results:
- Epigenetic gene dysregulation is evident across various thyroid carcinoma subtypes.
- Specific tumor suppressor and thyroid hormone-related genes are frequently epigenetically silenced.
- These epigenetic alterations contribute to thyroid cancer development and progression.
Conclusions:
- Epigenetic modifications are significant drivers in follicular cell-derived thyroid carcinomas.
- Epigenetics holds promise for developing novel diagnostic tools for thyroid cancer.
- Targeted epigenetic therapies represent a future direction for thyroid cancer treatment.
Related Concept Videos
01:37Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
01:46Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
01:46Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...